Sage Therapeutics (SAGE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
SAGE has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR (2026-04-11) ↗
SAGE is tracked by BiotechSigns with a current catalyst score of 50/100 and grade C. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
Sage Therapeutics (SAGE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
SAGE has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].